BRISBANE, CA, US
Breeze Bio, Inc.
From the company
BreezeBio (formerly GenEdit) is a genetic medicine company developing precision delivery of genetic medicines using its programmable NanoGalaxy® nanoparticle delivery platform. Its lead program, BRZ-101, is an HNP-mRNA immune modulation therapy designed to induce antigen-specific immune tolerance in Type 1 Diabetes. The company is also advancing programs for autoimmune disease and oncology.
Capabilities
Products & services
Capabilities 3
Materials 1
View classifications
- Materials (1)
- nanoparticles
Direct lines
Contact
Share quantities, requirements, and timing.
Send requirementsCompany record
Profile information
- Founded
- 2016
- Website
- www.breezebio.com
Source: company website
Start a conversation
Send your requirements
Quantities, certifications, delivery timing, and anything else needed to quote the work.